In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study
Cells · 2024
DOI: 10.3390/cells13131091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Tsai-Der Chuang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA. Hauptthemen laut MEDLINE: Sulfones, Leiomyoma, Nitriles, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Current medical therapies for fibroids have major limitations due to their hypoestrogenic side effects. Based on our previous work showing the activation of NF-kB in fibroids, we hypothesized that inhibiting NF-kB in vivo would result in the shrinkage of tumors and reduced inflammation. Fibroid xenografts were implanted in SCID mice and treated daily with Bay 11-7082 (Bay) or vehicle for two months. Bay treatment led to a 50% reduction in tumor weight. RNAseq revealed decreased expression of genes related to cell proliferation, inflammation, extracellular matrix (ECM) composition, and growth factor expression. Validation through qRT-PCR, Western blotting, ELISA, and immunohistochemistry (IHC) confirmed these findings. Bay treatment reduced mRNA expression of cell cycle regulators (CCND1, E2F1, and CKS2), inflammatory markers (SPARC, TDO2, MYD88, TLR3, TLR6, IL6, TNFα, TNFRSF11A, and IL1β), ECM remodelers (COL3A1, FN1, LOX, and TGFβ3), growth factors (PRL, PDGFA, and VEGFC), progesterone receptor, and miR-29c and miR-200c. Collagen levels were reduced in Bay-treated xenografts. Western blotting and IHC showed decreased protein abundance in certain ECM components and inflammatory markers, but not cleaved caspase three. Ki67, CCND1, and E2F1 expression decreased with Bay treatment. This preclinical study suggests NF-kB inhibition as an effective fibroid treatment, suppressing genes involved in proliferation, inflammation, and ECM remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA.
- Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, CA 90024, USA.
ORCID-Profile: Tsai-Der Chuang, Shawn Rysling, Omid Khorram
Förderung
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Chuang, T. D., Ton, N., Rysling, S., & Khorram, O. (2024). In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study. Cells. https://doi.org/10.3390/cells13131091
Vancouver
Chuang TD, Ton N, Rysling S, Khorram O. In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study. Cells. 2024. doi:10.3390/cells13131091
BibTeX
@article{Chuang2024,
author = {Chuang, Tsai-Der and Ton, Nhu and Rysling, Shawn and Khorram, Omid},
title = {In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13131091}
}
EUVIMED